0.0650
+0.0030
+(4.84%)
At close: April 17 at 5:35:02 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-4,976
-5,635
-12,143
-12,381
-5,224
Investing Cash Flow
-8
-19
-21
-14
-39
Financing Cash Flow
4,678
3,266
7,285
11,498
14,182
End Cash Position
2,702
2,245
4,634
9,456
10,304
Capital Expenditure
-4
-19
-21
-14
-39
Issuance of Capital Stock
7,188
3,383
85
7,219
8,797
Issuance of Debt
--
1,004
7,431
4,371
5,743
Repayment of Debt
-2,098
-943
--
--
--
Repurchase of Capital Stock
--
-1
-29
-1
-4
Free Cash Flow
-4,980
-5,654
-12,164
-12,395
-5,263
12/31/2020 - 9/30/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALVIO.PA Valerio Therapeutics Société anonyme
0.0688
+4.24%
ALINT.PA IntegraGen SA
0.5600
-0.88%
ALNEV.PA Neovacs S.A.
0.0219
-3.52%
TCRT Alaunos Therapeutics, Inc.
2.4800
-7.12%
BSEM BioStem Technologies, Inc.
12.17
-4.40%
PRTG Portage Biotech Inc.
7.84
+16.15%
RXRX Recursion Pharmaceuticals, Inc.
5.50
+3.38%